Specifically, CAPS promotes G0/G1-phase cell cycle arrest in leukemia, osteosarcoma, colon cancer and bladder cancer cells [38,39,73], as well as G2/M-phase arrest in KB squamous cell carcinoma and MDA-MB-231 breast cancer cells [43,47]. This evidence concerns the gene CAPS and urinary bladder carcinoma.